Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
Engineered T cells with chimeric antigen receptor (CAR) are emerging as an effective cancer therapy. Here the authors show that CAR T cells recognizing self-MHC can be ‘tuned’ ex vivo via CAR downregulation and CAR T cell death to generate a CAR T pool specifically targeting tumor cells with high MH...
Enregistré dans:
Auteurs principaux: | Chungyong Han, Su-Jung Sim, Seon-Hee Kim, Rohit Singh, Sunhee Hwang, Yu I. Kim, Sang H. Park, Kwang H. Kim, Don G. Lee, Ho S. Oh, Sangeun Lee, Young H. Kim, Beom K. Choi, Byoung S. Kwon |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2cb448a0b80d4a85bfbe75a3ddee2e23 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study
par: Kiwan Kim, et autres
Publié: (2021) -
Multimerization is required for antigen binding activity of an engineered IgM/IgG chimeric antibody recognizing a skin-related antigen
par: Kwesi Teye, et autres
Publié: (2017) -
Chimeric antigen receptor modified T-cells for cancer treatment
par: Xiao Han, et autres
Publié: (2018) -
Effective chimeric antigen receptor T cells against SARS-CoV-2
par: Xueyang Guo, et autres
Publié: (2021) -
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
par: Cristina Aparicio, et autres
Publié: (2021)